mRNA IP will be hot property beyond the pandemic
$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field
Stay updated with breaking news from Alerts Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field
The Long Read: Justice Manmohan Singh was the chair of the recently abolished Intellectual Property Appellate Board and before that sat on the bench of the Delhi High Court where he presided over a series of landmark patent cases. In an exclusive interview, he talks about his shock at the Indian government's decision to do away with the board but argues that rights holders should not lose hope for the future
01 Jun 2021 @IAM_Alerts Not many companies make public how much they spend on IP royalties, but Xiaomi does. In Q1, the Chinese company rac… https://t.co/ky9qvCCgWjRead more 01 Jun 2021 01 Jun 2021 @IAM_Alerts BREAKING NEWS - Nokia and Daimler settle long-running patent dispute. German company will pay licensing fee to acce… https://t.co/qak9FwfL60Read more 31 May 2021 @IAM_Alerts As another major Chinese corporate joins its ranks, the OIN approaches...